[Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study].

Date publication

mars 2017

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CORMIER Luc

Tous les auteurs :
Léon P, Cancel-Tassin G, Koutlidis N, Calves J, Funes de la Vega M, Fournier G, Valeri A, Cormier L, Larré S, Cussenot O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28258910

Résumé

Currently, the French High Authority for Health does not recommend mass screening for prostate cancer (PCa), due to the risk of over-treatment, notably of low risk patients. Our study is intended to reflect the therapeutic attitudes for the management of patients classified as low risk of progression in French clinical centers.

Mots clés

Biopsies, Cancer de la prostate, Faible risque, Low risk, Management, Prise en charge, Prostate cancer, Prostatectomie radicale, Radical prostatectomy

Référence

Prog. Urol.. 2017 Mar;27(3):158-165